J&J Announces Possible Resolution Of Ovarian Cancer Talc MDL
TRENTON, N.J. — Johnson & Johnson on July 27 announced an agreement in which the company would pay $5.5 billion to resolve the multidistrict ovarian cancer talc litigation and related state...To view the full article, register now.
Already a subscriber? Click here to view full article